Clinical Trial Update: INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for INITIATE Plus studying initiation of insulin to reach A1c targets in type 2 diabetes, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED